According to OptiNose's latest financial reports the company's current earnings (TTM) are -$15.96 M. In 2022 the company made an earning of -$57.99 M an increase over its 2021 earnings that were of -$66.33 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$15.96 M | -72.49% |
2022 | -$57.99 M | -12.56% |
2021 | -$66.33 M | -23.57% |
2020 | -$86.78 M | -13.59% |
2019 | -$0.11 B | 3.08% |
2018 | -$97.43 M | 102.65% |
2017 | -$48.08 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 1,055.32% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | 18.77% | ๐บ๐ธ USA |